These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26082230)

  • 1. Strategies for Engineering Protein N-Glycosylation Pathways in Mammalian Cells.
    Wang Q; Stuczynski M; Gao Y; Betenbaugh MJ
    Methods Mol Biol; 2015; 1321():287-305. PubMed ID: 26082230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans.
    Shi HH; Goudar CT
    Biotechnol Bioeng; 2014 Oct; 111(10):1907-19. PubMed ID: 24975601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoengineering of CHO Cells to Improve Product Quality.
    Wang Q; Yin B; Chung CY; Betenbaugh MJ
    Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-resistant CHO glycosylation mutants.
    Patnaik SK; Stanley P
    Methods Enzymol; 2006; 416():159-82. PubMed ID: 17113866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal and consistent protein glycosylation in mammalian cell culture.
    Hossler P; Khattak SF; Li ZJ
    Glycobiology; 2009 Sep; 19(9):936-49. PubMed ID: 19494347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoengineering of Mammalian Expression Systems on a Cellular Level.
    Heffner KM; Wang Q; Hizal DB; Can Ö; Betenbaugh MJ
    Adv Biochem Eng Biotechnol; 2021; 175():37-69. PubMed ID: 29532110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyco-Mapper: A Chinese hamster ovary (CHO) genome-specific glycosylation prediction tool.
    Kremkow BG; Lee KH
    Metab Eng; 2018 May; 47():134-142. PubMed ID: 29522825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian Systems Biotechnology Reveals Global Cellular Adaptations in a Recombinant CHO Cell Line.
    Yusufi FNK; Lakshmanan M; Ho YS; Loo BLW; Ariyaratne P; Yang Y; Ng SK; Tan TRM; Yeo HC; Lim HL; Ng SW; Hiu AP; Chow CP; Wan C; Chen S; Teo G; Song G; Chin JX; Ruan X; Sung KWK; Hu WS; Yap MGS; Bardor M; Nagarajan N; Lee DY
    Cell Syst; 2017 May; 4(5):530-542.e6. PubMed ID: 28544881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glyco-engineered CHO cell lines producing alpha-1-antitrypsin and C1 esterase inhibitor with fully humanized N-glycosylation profiles.
    Amann T; Hansen AH; Kol S; Hansen HG; Arnsdorf J; Nallapareddy S; Voldborg B; Lee GM; Andersen MR; Kildegaard HF
    Metab Eng; 2019 Mar; 52():143-152. PubMed ID: 30513349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
    Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
    Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Markov chain model for N-linked protein glycosylation--towards a low-parameter tool for model-driven glycoengineering.
    Spahn PN; Hansen AH; Hansen HG; Arnsdorf J; Kildegaard HF; Lewis NE
    Metab Eng; 2016 Jan; 33():52-66. PubMed ID: 26537759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern.
    Schähs M; Strasser R; Stadlmann J; Kunert R; Rademacher T; Steinkellner H
    Plant Biotechnol J; 2007 Sep; 5(5):657-63. PubMed ID: 17678502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation control technologies for recombinant therapeutic proteins.
    Gupta SK; Shukla P
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry and regulatory experience of the glycosylation of monoclonal antibodies.
    Read EK; Park JT; Brorson KA
    Biotechnol Appl Biochem; 2011; 58(4):213-9. PubMed ID: 21838794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
    Wong NS; Yap MG; Wang DI
    Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The choice of mammalian cell host and possibilities for glycosylation engineering.
    Butler M; Spearman M
    Curr Opin Biotechnol; 2014 Dec; 30():107-12. PubMed ID: 25005678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sweet branch of metabolic engineering: cherry-picking the low-hanging sugary fruits.
    Chen R
    Microb Cell Fact; 2015 Dec; 14():197. PubMed ID: 26655367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Glyco-Engineering in Eukaryotic Cells and Selected Applications.
    Piller F; Mongis A; Piller V
    Methods Mol Biol; 2015; 1321():335-59. PubMed ID: 26082233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cells.
    Dreesen IA; Fussenegger M
    Biotechnol Bioeng; 2011 Apr; 108(4):853-66. PubMed ID: 21404259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.